<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle><![CDATA[RAPID: Mixed-Dimensional Heterostructure Materials based SERS for Trace Level Fingerprint Identification of SARS-CoV-2 RNA]]></AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>05/15/2020</AwardEffectiveDate>
<AwardExpirationDate>12/31/2022</AwardExpirationDate>
<AwardTotalIntnAmount>200000.00</AwardTotalIntnAmount>
<AwardAmount>200000</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>03070000</Code>
<Directorate>
<Abbreviation>MPS</Abbreviation>
<LongName>Direct For Mathematical &amp; Physical Scien</LongName>
</Directorate>
<Division>
<Abbreviation>DMR</Abbreviation>
<LongName>Division Of Materials Research</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Debasis Majumdar</SignBlockName>
<PO_EMAI>dmajumda@nsf.gov</PO_EMAI>
<PO_PHON>7032924709</PO_PHON>
</ProgramOfficer>
<AbstractNarration><![CDATA[Current novel coronavirus infection (COVID-19) diagnostic tests, used worldwide, take significant time, typically more than a day, to confirm results. There is an urgent need for a rapid coronavirus test platform throughout the world at this moment. This RAPID project will develop sensitive, fast and simple-to-use optical techniques to detect viral-RNA using Raman spectroscopy, which has capability for specific identification of COVID-19. The goal of this project is to design new material-based robust optical platform to detect trace level virus RNA. This will be accomplished by measuring the Raman signal from COVID-19 RNA. The expected outcome is a nanomaterial based technology underlying a portable device for accurate and immediate diagnosis of viral infections from COVID-19. The proposed research will enable approaches that mitigate the negative impacts of COVID-19 on public health, society, and the economy. This Rapid Response Research (RAPID) grant supports research with funding from the Partnerships for Research and Education in Materials (PREM) Program in the Division of Materials Research of the Mathematical and Physical Sciences Directorate, with co-funding from the HBCU-EiR program.&lt;br/&gt;&lt;br/&gt;Novel material-based technologies for sensitive and rapid identification of COVID-19 is very important to tackle COVID-19 epidemic threat. The current project will contribute towards the development of novel mixed dimensional heterostructure based surface enhanced Raman spectroscopy (SERS) platform for highly efficient and immediate fingerprint identification of SARS-CoV-2 RNA. Specifically, the objectives include development of innovative 2D-0D, 1D-0D, and 2D-1D heterostructure building blocks and creating novel heterostructure-based SERS platform-based technology. The mixed-dimensional heterostructure material will offer opportunities for revolutionary advances in designing SERS platform. The SERS platform will provide accurate identification of the COVID-19 RNA, which can be used in both clinical and field settings. The RAPID program will serve as the bridge among scientific research, technological development, and educational activities for African American students.&lt;br/&gt;&lt;br/&gt;This grant is being awarded using funds made available by the Coronavirus Aid, Relief, and Economic Security (CARES) Act supplemental funds allocated to MPS.&lt;br/&gt;&lt;br/&gt;This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.]]></AbstractNarration>
<MinAmdLetterDate>05/12/2020</MinAmdLetterDate>
<MaxAmdLetterDate>05/12/2020</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.049</CFDA_NUM>
<NSF_PAR_USE_FLAG>1</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>2030439</AwardID>
<Investigator>
<FirstName>Paresh</FirstName>
<LastName>Ray</LastName>
<PI_MID_INIT>C</PI_MID_INIT>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Paresh C Ray</PI_FULL_NAME>
<EmailAddress><![CDATA[paresh.c.ray@jsums.edu]]></EmailAddress>
<NSF_ID>000300086</NSF_ID>
<StartDate>05/12/2020</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Jackson State University</Name>
<CityName>JACKSON</CityName>
<ZipCode>392170002</ZipCode>
<PhoneNumber>6019792008</PhoneNumber>
<StreetAddress>1400 J R LYNCH ST</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>Mississippi</StateName>
<StateCode>MS</StateCode>
<CONGRESSDISTRICT>02</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>MS02</CONGRESS_DISTRICT_ORG>
<ORG_UEI_NUM>WFVHMSF6BU45</ORG_UEI_NUM>
<ORG_LGL_BUS_NAME>JACKSON STATE UNIVERSITY</ORG_LGL_BUS_NAME>
<ORG_PRNT_UEI_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[Jackson State University]]></Name>
<CityName/>
<StateCode>MS</StateCode>
<ZipCode>392170002</ZipCode>
<StreetAddress/>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Mississippi</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>02</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>MS02</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>070Y</Code>
<Text>HBCU-EiR - HBCU-Excellence in</Text>
</ProgramElement>
<ProgramElement>
<Code>158Y</Code>
<Text>COVID-19 Research</Text>
</ProgramElement>
<ProgramReference>
<Code>096Z</Code>
<Text>COVID-19 Research</Text>
</ProgramReference>
<ProgramReference>
<Code>7237</Code>
<Text>NANO NON-SOLIC SCI &amp; ENG AWD</Text>
</ProgramReference>
<ProgramReference>
<Code>7914</Code>
<Text>RAPID</Text>
</ProgramReference>
<ProgramReference>
<Code>8614</Code>
<Text>Nanomaterials</Text>
</ProgramReference>
<ProgramReference>
<Code>9150</Code>
<Text>EXP PROG TO STIM COMP RES</Text>
</ProgramReference>
<Appropriation>
<Code>1N20</Code>
<Name>R&amp;RA CARES Act DEFC N</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<Fund>
<Code>010N2021DB</Code>
<Name><![CDATA[R&RA CARES Act DEFC N]]></Name>
<FUND_SYMB_ID>040100</FUND_SYMB_ID>
</Fund>
<FUND_OBLG>2020~200000</FUND_OBLG>
<POR>
<DRECONTENT><![CDATA[<div class="porColContainerWBG"> <div class="porContentCol"><p>Infectious diseases by pathogenic microorganisms are one of the leading causes of mortality worldwide. Healthcare and socio-economic development have been seriously affected for different civilizations because of bacterial and viral infections. As per the World Health Organization (WHO), the current pandemic by coronavirus disease 2019 (COVID-19) due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) virus is responsible for more than 6.4 M death worldwide until now. Since the gold standard polymerase chain reaction (PCR) test is more time-consuming, the health care system cannot test all symptomatic and asymptomatic Covid patients every day, which is extremely important to tackle the outbreak. One of the significant challenges during the current pandemic is developing mass testing tools, which is critical to control the virus spread in the community.</p> <p>Aiming for the targeted diagnosis of deadly virus, we have developed nanomaterials with various sizes, shapes, and dimensions. These nanomaterials have been used to identify biomolecules via unique optical, electrical, magnetic, structural, and functional properties, which are lacking in other materials. For this purpose, the bioconjugated nanoparticle has been designed via surface coating with polyethylene glycol (PEG) and then conjugated with antibodies, DNA, RNA, or peptide aptamers. We have designed nanomaterial-based surface-enhanced Raman scattering (SERS) spectroscopy, which has the capability for very low-level fingerprint identification of SARS-CoV-2. We have reported how bioconjugated nanomaterials can be used for possible applications in SARS-CoV-2 diagnostics. We have shown how the plasmonic properties of nanomaterials can be used for the development of naked-eye colorimetric identification of the SERS-CoV-2 viral RNA, antigen, and antibody. During the funding, we have published five papers in high impact factor journals.</p> <p>&nbsp;</p> <p>During the funding period, the program has supported a total of 1 postdoc, 1 undergraduate and 2 graduate students. After finishing master&rsquo;s degree, Kaelin Gates has joined as PhD students in the department of Chemistry at Louisiana State University. Shamily Patibandla was a graduate student in this grant, after finishing her PhD, she has joined as postdoc in the Institute for Shock Physics (ISP) at Washington State University (WSU). Dr. Sudarson Sekhar Sinha, who was a postdoc in this grant has joined at biotechnology industry in Huntsville Alabama</p> <p>&nbsp;</p><br> <p>            Last Modified: 01/08/2023<br>      Modified by: Paresh&nbsp;C&nbsp;Ray</p> </div> <div class="porSideCol"></div> </div>]]></DRECONTENT>
<POR_COPY_TXT><![CDATA[ Infectious diseases by pathogenic microorganisms are one of the leading causes of mortality worldwide. Healthcare and socio-economic development have been seriously affected for different civilizations because of bacterial and viral infections. As per the World Health Organization (WHO), the current pandemic by coronavirus disease 2019 (COVID-19) due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) virus is responsible for more than 6.4 M death worldwide until now. Since the gold standard polymerase chain reaction (PCR) test is more time-consuming, the health care system cannot test all symptomatic and asymptomatic Covid patients every day, which is extremely important to tackle the outbreak. One of the significant challenges during the current pandemic is developing mass testing tools, which is critical to control the virus spread in the community.  Aiming for the targeted diagnosis of deadly virus, we have developed nanomaterials with various sizes, shapes, and dimensions. These nanomaterials have been used to identify biomolecules via unique optical, electrical, magnetic, structural, and functional properties, which are lacking in other materials. For this purpose, the bioconjugated nanoparticle has been designed via surface coating with polyethylene glycol (PEG) and then conjugated with antibodies, DNA, RNA, or peptide aptamers. We have designed nanomaterial-based surface-enhanced Raman scattering (SERS) spectroscopy, which has the capability for very low-level fingerprint identification of SARS-CoV-2. We have reported how bioconjugated nanomaterials can be used for possible applications in SARS-CoV-2 diagnostics. We have shown how the plasmonic properties of nanomaterials can be used for the development of naked-eye colorimetric identification of the SERS-CoV-2 viral RNA, antigen, and antibody. During the funding, we have published five papers in high impact factor journals.     During the funding period, the program has supported a total of 1 postdoc, 1 undergraduate and 2 graduate students. After finishing masterâ€™s degree, Kaelin Gates has joined as PhD students in the department of Chemistry at Louisiana State University. Shamily Patibandla was a graduate student in this grant, after finishing her PhD, she has joined as postdoc in the Institute for Shock Physics (ISP) at Washington State University (WSU). Dr. Sudarson Sekhar Sinha, who was a postdoc in this grant has joined at biotechnology industry in Huntsville Alabama          Last Modified: 01/08/2023       Submitted by: Paresh C Ray]]></POR_COPY_TXT>
</POR>
</Award>
</rootTag>
